Search hospitals > Michigan > Troy
Michigan Institute of Urology-Town Center
Claim this profileTroy, Michigan 48084
Global Leader in Prostate Cancer
Global Leader in Bladder Cancer
Conducts research for Lung Cancer
Conducts research for Breast Cancer
Conducts research for Breast cancer
96 reported clinical trials
11 medical researchers
Summary
Michigan Institute of Urology-Town Center is a medical facility located in Troy, Michigan. This center is recognized for care of Prostate Cancer, Bladder Cancer, Lung Cancer, Breast Cancer, Breast cancer and other specialties. Michigan Institute of Urology-Town Center is involved with conducting 96 clinical trials across 132 conditions. There are 11 research doctors associated with this hospital, such as Dana Zakalik, Andrew A. Muskovitz, Faisal Musa, and Joseph M. Anderson.Area of expertise
1Prostate Cancer
Global LeaderStage IV
PSA
Gleason Score
2Bladder Cancer
Global LeaderTop PIs
Dana ZakalikBeaumont Hospital - Farmington Hills2 years of reported clinical research
Studies Pancreatic Cancer
Studies Cancer
12 reported clinical trials
46 drugs studied
Andrew A. MuskovitzWilliam Beaumont Hospital-Royal Oak4 years of reported clinical research
Studies Colon Cancer
Studies Colorectal Cancer
8 reported clinical trials
19 drugs studied
Faisal MusaMichigan Center of Medical Research2 years of reported clinical research
Studies Immune Thrombocytopenic Purpura
Studies Colorectal Cancer
5 reported clinical trials
12 drugs studied
Joseph M. AndersonBeaumont Hospital - Dearborn11 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
3 reported clinical trials
7 drugs studied
Clinical Trials running at Michigan Institute of Urology-Town Center
Lung Cancer
Breast Cancer
Esophageal cancer
Bladder Cancer
Prostate Cancer
Breast cancer
Ovarian Cancer
Stomach Cancer
Colorectal Cancer
Gastric cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Biomarker Screening Test
for Lung Cancer
This study is part of the development of a non-invasive lung cancer screening test which aim to identify early-stage lung cancer in patients at high risk for lung cancer.
Recruiting1 award N/A3 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Michigan Institute of Urology-Town Center?
Michigan Institute of Urology-Town Center is a medical facility located in Troy, Michigan. This center is recognized for care of Prostate Cancer, Bladder Cancer, Lung Cancer, Breast Cancer, Breast cancer and other specialties. Michigan Institute of Urology-Town Center is involved with conducting 96 clinical trials across 132 conditions. There are 11 research doctors associated with this hospital, such as Dana Zakalik, Andrew A. Muskovitz, Faisal Musa, and Joseph M. Anderson.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.